Comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data"
- PMID: 35713777
- DOI: 10.1007/s40264-022-01191-2
Comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data"
Comment in
-
Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.Drug Saf. 2022 Mar;45(3):287-295. doi: 10.1007/s40264-022-01166-3. Epub 2022 Mar 5. Drug Saf. 2022. PMID: 35247195
-
Authors' Reply to Noguchi's comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.".Drug Saf. 2022 Jul;45(7):813-814. doi: 10.1007/s40264-022-01192-1. Epub 2022 Jun 17. Drug Saf. 2022. PMID: 35713778 No abstract available.
Comment on
-
Authors' Reply to Noguchi's comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.".Drug Saf. 2022 Jul;45(7):813-814. doi: 10.1007/s40264-022-01192-1. Epub 2022 Jun 17. Drug Saf. 2022. PMID: 35713778 No abstract available.
References
Reference
-
- Alkabbani W, Pelletier R, Beazely MA, Labib Y, Quan B, Gamble JM. Drug-drug interaction of the sodium glucose co-transporter 2 inhibitors with statins and myopathy: a disproportionality analysis using adverse events reporting data. Drug Saf. 2022;45:287–95 https://doi.org/10.1007/s40264-022-01166-3 . - DOI - PubMed
-
- Antonazzo IC, Poluzzi E, Forcesi E, Salvo F, Pariente A, Marchesini G, De Ponti F, Raschi E. Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug-drug interactions through the FDA adverse event reporting system. Acta Diabetol. 2020;57:71–80. https://doi.org/10.1007/s00592-019-01378-7 . - DOI - PubMed
-
- van Puijenbroek EP, Egberts AC, Heerdink ER, Leufkens HG. Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol. 2000;56:733–8. https://doi.org/10.1007/s002280000215 . - DOI - PubMed
-
- Thakrar BT, Grundschober SB, Doessegger L. Detecting signals of drug-drug interactions in a spontaneous reports database. Br J Clin Pharmacol. 2007;64:489–95. https://doi.org/10.1111/j.1365-2125.2007.02900.x . - DOI - PubMed - PMC
-
- Kuss O, Rathmann W. A missed protective drug-drug interaction of DPP-4 inhibitors and statins on myopathy risk. Acta Diabetol. 2020;57:113–4. https://doi.org/10.1007/s00592-019-01440-4 . - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
